Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Actavis UK Ltd
Whiddon Valley, Barnstaple, Devon, EX32 8NS, UK
Telephone: +44 (0)1271 311 200
Fax: +44 (0)1271 346 106
WWW: http://www.actavis.co.uk
Medical Information Direct Line: +44 (0)1271 311 257
Medical Information e-mail: medinfo@actavis.co.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 21/02/2012
PIL Mirtazapine 30mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 21/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to how the medicine works
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about overdose
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • addition/update of safety device
  • Change to dosage and administration
  • Changes to therapeutic indications
Updated on 20/07/2011 and displayed until 21/02/2012
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to how the medicine works
  • Change to side-effects
Updated on 17/03/2011 and displayed until 20/07/2011
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
Updated on 28/08/2008 and displayed until 17/03/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 24/04/2008 and displayed until 28/08/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 13/12/2007 and displayed until 24/04/2008
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 19/10/2007 and displayed until 13/12/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 26/06/2006 and displayed until 19/10/2007
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 16/06/2006 and displayed until 26/06/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  mirtazapine